SBC (SBC Medical Group Holdings Incorporated Common Stock) Stock

Aug 3, 2026

▲ +3.3%today

SBC Medical to Announce 2Q 2026 Financial Results

SBC Medical Group Holdings Incorporated will announce its financial results for Q2 2026 on August 13, 2026. The announcement will precede a conference call at 8:30 a.m. ET, which will include a Q&A session for analysts and investors. The company continues to expand its operations and is recognized for its quality medical services.

Jul 15, 2026

SBC Medical to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:30 a.m. ET

SBC Medical Group Holdings will present at the 'Health, Wellness & Longevity' virtual conference hosted by Maxim Group on July 22nd. Key executives will discuss consumer wellness trends and innovations in the healthcare sector. The event aims to address emerging consumer preferences and regulatory challenges in health-related markets.

Jul 8, 2026

SBC Medical Launches Japan's First Specialized Men's Beard Hair Removal Clinic, Introducing a Scalable, Capital-Efficient Growth Platform

SBC Medical Group Holdings has announced the opening of SBC MEN'S FLASH CLINIC in Ikebukuro, Tokyo, on August 6, 2026. This clinic is Japan's first dedicated to men's beard hair removal, aiming to capitalize on the growing demand for aesthetic services among men. The clinic features a standardized model designed for scalability and efficiency, enhancing customer acquisition and service delivery in the aesthetic healthcare market.

Jul 2, 2026

2026 Annual Meeting

The article provides an overview of the 2026 Annual Meeting for SBC, detailing various aspects such as stock information, financial data, corporate governance, and investor relations. It highlights the structure of the meeting and the availability of resources for stakeholders. However, no specific details about the meeting's agenda or outcomes are mentioned.

Jun 30, 2026

「日経マネー資産運用＆IRフォーラム in 関西2026」に出展・登壇

SBC Medical Group Holdings is set to host an investor relations event titled "Japan Medical Production & IR Forum in Kansai 2026" on July 11-12, 2026. The event will highlight the company's focus on beauty medicine and longevity, aiming to attract individual investors. SBC is expected to present its business strategies and growth potential during this two-day forum.

Jun 4, 2026

「みん就 2027年卒の就活生が選んだみんなの新卒就職人気企業ランキング」で5部門1位を獲得

SBC Medical Group Holdings has announced its achievement of a top ranking in the new recruitment sector for 2027. The company aims to enhance its recruitment strategies and training programs to attract more talent. This achievement reflects the growing demand for skilled professionals in the healthcare industry, particularly in specialized fields. The focus on improving recruitment processes is expected to support the company's future growth.

Yahoo!ファイナンス掲載のお知らせ

SBC Medical Group Holdings, Inc. recently held an investor relations seminar in collaboration with Yahoo!, which attracted over 663,000 attendees. The seminar focused on the company's initiatives in AI and longevity, highlighting their strategic direction for future growth. This partnership is expected to enhance SBC's market presence and investor engagement.

日経マネー資産運用＆IRフォーラム in 関西2026

The article provides an overview of SBC's investor relations activities and stock information, including financial details and corporate governance. It outlines various aspects such as SEC filings, quarterly results, and upcoming events. However, it lacks specific news or developments that could influence investor sentiment.

5 Virtual Conference After 1Q

The article discusses an upcoming virtual conference scheduled after the first quarter. It provides an overview of stock information, financial data, and corporate governance details. Additionally, it highlights the company's events and presentations, along with contact information for investor relations.

2Q2026 Earnings Call

The article provides an overview of the 2Q2026 earnings call for SBC. It outlines various sections including stock information, financial data, corporate governance, and investor relations. However, specific financial results or insights from the earnings call are not detailed in the text.

May 26, 2026

Participation in several upcoming investor conferences in May and June 2026

SBC Medical Group Holdings Incorporated announced its participation in several investor conferences scheduled for May and June 2026. The company will deliver webcast presentations and hold one-on-one meetings with institutional investors. This engagement highlights SBC Medical's commitment to enhancing its visibility and expanding its global operations in various healthcare fields.

May 22, 2026

SBC Medical and BLEZ ASIA Celebrate Opening of New Aesthetic Dermatology Section at BLEZ CLINIC in Bangkok

SBC Medical Group Holdings has partnered with BLEZ ASIA to inaugurate a new aesthetic dermatology section at BLEZ CLINIC in Bangkok. This initiative aims to provide high-quality aesthetic healthcare services tailored to Japanese expatriates. The section will initially offer pico laser treatments and is set to launch in June 2026, with plans for future expansion across Thailand and ASEAN.

May 15, 2026

SBC Medical Group Holdings annonce ses résultats financiers pour le premier trimestre 2026

SBC Medical Group Holdings has announced its financial results for the first quarter of 2026. However, the article does not provide specific details about the results or any significant developments. The announcement appears to be routine without any notable highlights or concerns.

May 15, 2026

SBC Medical Group Holdings gibt die Finanzergebnisse für das erste Quartal 2026 bekannt

SBC Medical Group Holdings has announced its financial results for the first quarter of 2026. The article provides limited details about the performance or specific figures reported. Further insights into the company's financial health or market impact are not available.

Riassunto: SBC Medical Group Holdings annuncia i risultati finanziari del primo trimestre 2026

SBC Medical Group Holdings has announced its financial results for the first quarter of 2026. However, the article lacks specific details regarding the performance metrics or any significant changes in the company's financial health. This absence of information raises concerns about the transparency and overall performance of the company during this period.

Samenvatting: SBC Medical Group Holdings maakt de financiële resultaten over het eerste kwartaal van 2026 bekend

SBC Medical Group Holdings has announced its financial results for the first quarter of 2026. The article provides a brief overview but lacks detailed information regarding the specifics of the financial performance. No significant insights or implications are discussed in the summary provided.

Resumen: SBC Medical Group Holdings anuncia los resultados financieros del primer trimestre de 2026

SBC Medical Group Holdings released its financial results for the first quarter of 2026. The article does not provide specific details regarding the performance metrics or any notable achievements. Overall, the information appears to be limited and lacks substantial insights into the company's financial health.

SBC Medical Group Holdings Announces First Quarter 2026 Financial Results IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Medical Ser

SBC Medical Group Holdings announced its financial results for the first quarter of 2026, revealing a revenue decline of 9% year-over-year to $43 million. Net income also saw a considerable drop by 47%, with earnings per share falling to $0.11. Despite these downturns, the company reported an increase in the number of franchise locations and a rise in customer count. Looking ahead, SBC Medical plans to enhance its services and expand its presence in the aesthetic dermatology market while leveraging AI technologies.

Samenvatting: SBC Medical maakt bekend dat de eerder aangekondigde secundaire openbare aanbieding van 3,1 miljoen gewone aandelen is afgerond

SBC Medical Group Holdings has successfully completed its previously announced secondary public offering of 3.1 million common shares at a price of $3.25 per share. The offering raised approximately $10.1 million for the selling shareholder, Dr. Yoshiyuki Aikawa. The company did not sell any additional shares in this offering.

SBC Medical宣布完成先前公佈的310萬股普通股二次公開發行

SBC Medical has announced a stock offering of 31 million shares. However, the article provides minimal details about the offering's purpose or potential impact on the company. The lack of information raises concerns about transparency and investor confidence. Further context is needed to understand the significance of this announcement.

SBC Medical宣布已完成此前公布的310万股普通股二次公开发行

SBC Medical has announced the completion of a public offering of 310 million shares. However, the article does not provide any details about the offering or its implications for the company. The lack of information leaves readers without a clear understanding of the announcement's significance.

Riassunto: SBC Medical annuncia la chiusura dell'offerta pubblica secondaria annunciata in precedenza del valore di 3,1 milioni di azioni ordinarie

SBC Medical has announced the closure of its previously announced secondary public offering of 3.1 million common shares. This development indicates the company's ongoing efforts to raise capital through public markets. Further details regarding the offering and its implications for SBC Medical's financial position were not disclosed.

SBC Medical anuncia el cierre de la venta secundaria de 3,1 millones de acciones ordinarias previamente informada

SBC Medical has announced the completion of a secondary sale of 3.1 million common shares. This transaction was previously reported and is part of the company's ongoing financial strategy. Further details regarding the implications of this sale were not disclosed in the announcement.

SBC Medical gibt den Abschluss der zuvor angekündigten Sekundäremission von 3,1 Millionen Stammaktien bekannt

SBC Medical has announced the completion of a secondary offering of 3.1 million shares. This move is part of their ongoing financial strategy. Further details regarding the implications of this offering were not disclosed in the announcement.

SBC Medical annonce la clôture de son offre publique secondaire annoncée précédemment se montant à 3,1 millions d'actions ordinaires

SBC Medical has announced the closure of its previously announced secondary public offering, which involved 3.1 million common shares. This move is part of the company's ongoing efforts to enhance its capital structure. Further details regarding the offering's impact on the company's operations were not disclosed.

SBC Medical anuncia a conclusão da oferta pública secundária previamente anunciada de 3,1 milhões de ações ordinárias

SBC Medical Group Holdings announced the successful completion of its previously announced secondary public offering of 3.1 million ordinary shares at $3.25 per share. The offering raised approximately $10.1 million for the selling shareholder, Dr. Yoshiyuki Aikawa. SBC Medical did not sell any shares in this offering, which was managed by Maxim Group LLC and Roth Capital Partners.

Apr 21, 2026

SBCメディカル、既に公表済みの普通株式3,100,000株の売出しに係るセカンダリー公募の完了を発表

SBC Medical Group Holdings Incorporated has announced the successful completion of a public offering of 100,000 shares at a price of $3.25 per share. This offering is part of the company's strategy to expand its diverse medical practices and enhance its market presence. The company aims to provide high-quality medical services and is positioned for significant growth in the coming years.

Apr 21, 2026

SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock

SBC Medical Group Holdings has successfully closed its secondary public offering of 3.1 million shares at $3.25 per share, generating approximately $10.1 million for the Selling Stockholder. The offering was managed by Maxim Group LLC and Roth Capital Partners. SBC Medical continues to expand its operations in various medical fields, enhancing its international reputation.

SBC Medical gibt Preisfestsetzung für die Zweitplatzierung von 3,1 Millionen Stammaktien bekannt

SBC Medical announced the pricing for a secondary placement of 3.1 million common shares. However, the article provides minimal details regarding the pricing strategy or potential market impact. The lack of context may raise concerns among investors about the company's transparency and future prospects.

SBC Medical宣布310萬股普通股二次公開發行定價

SBC Medical has announced a second public offering of shares, but the article provides minimal information. Key details regarding the offering's purpose and potential impact on the company are absent. This lack of information may leave investors uncertain about the announcement's significance.

Samenvatting: SBC Medical onthult de prijs van de secundaire openbare aanbieding van 3,1 miljoen gewone aandelen

SBC Medical has announced the pricing for its secondary public offering of 3.1 million common shares. The details surrounding the offering are limited, and the announcement does not provide further context or implications for the company. Investors may be awaiting additional information regarding the use of proceeds or market response.

Riassunto: SBC Medical annuncia la determinazione del prezzo dell'offerta pubblica secondaria di 3,1 milioni di azioni ordinarie

SBC Medical has announced the pricing of its secondary public offering of 3.1 million ordinary shares. The announcement comes as part of the company's ongoing efforts to raise capital. Further details regarding the offering's implications or use of proceeds were not provided in the article.

SBC Medical annonce le prix de son offre publique secondaire portant sur 3,1 millions d’actions ordinaires

SBC Medical has announced the pricing of its secondary public offering of 3.1 million common shares. This move is part of the company's strategy to raise additional capital. The offering is expected to enhance SBC Medical's financial position, although specific details on the use of proceeds were not disclosed.

SBC Medical anuncia el precio de su oferta pública secundaria de 3,1 millones de acciones ordinarias

SBC Medical has announced the pricing of its secondary public offering of 3.1 million common shares. The details surrounding the offering, including its implications for the company, have not been elaborated upon in the article.

SBC Medical anuncia preço de oferta pública secundária de 3,1 milhões de ações ordinárias

SBC Medical has announced the price for its secondary public offering of 3.1 million ordinary shares. The announcement details the financial aspects of the offering, but does not provide further information on the implications or expected outcomes of this move.

Apr 19, 2026

SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock

SBC Medical has announced the pricing of a secondary public offering for 3.1 million shares of common stock. This move is part of the company's strategy to raise capital. Further details regarding the offering and its implications were not provided in the announcement.

Mar 27, 2026

SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results Q4 EPS more than doubles to $0.14 as profitability improves significantly year over year IRVINE, Calif. --SBC Medical Group Holdings Incorporated

SBC Medical Group Holdings Incorporated announced its financial results for Q4 and the full year of 2025, highlighting a significant improvement in profitability. Earnings per share increased to $0.14, a 133% rise from the previous year, while net income grew by 117% year-over-year. However, total revenues decreased by 11% in Q4 and 15% for the full year, attributed to recent structural changes and franchise fee revisions. The company intends to focus on its multi-brand strategy and expand its operations in international markets moving forward.

Mar 13, 2026

SBC Medical to Announce Q4 and Full‑Year 2025 Financial Results

SBC Medical Group Holdings Incorporated announced it will release its Q4 and full-year 2025 financial results on March 27, 2026. An earnings conference call will follow to discuss financial performance and operational highlights. The company is focused on expanding its medical services and enhancing its international reputation.

Jan 5, 2026

SBC Medical Accelerates Global Expansion with Strategic Investment and Alliance with a Leading U.S. MedSpa Platform OrangeTwist as Part of Broader Growth Strategy 　 IRVINE, Calif., Jan.5, 2026 - SBC Medical Group

SBC Medical Group has announced a strategic investment and partnership with U.S.-based MedSpa platform OrangeTwist, marking a significant step in its global expansion strategy. This collaboration aims to leverage cross-border synergies to establish a leading position in the U.S. medical aesthetics market. The partnership is part of a phased roadmap for international growth and reflects SBC Medical's objectives to enhance service delivery and operational efficiency while tapping into the rapidly growing wellness market.

Dec 31, 2025

SBC Medical Announces Capital Strategy: Effectiveness of Form S-3 Registration Statement and Approval of Up to $20 Million Share Repurchase Program

SBC Medical Group Holdings Incorporated has announced a new capital strategy that includes the effective Form S-3 registration statement and an approval for a $20 million share repurchase program. The SEC declared the registration statement effective on December 30, 2025, enabling the company to raise up to $50 million in the future. The share repurchase program allows the company to buy back its own shares over the next year and a half, with the flexibility to modify or terminate the program at any time. The company aims to conduct these repurchases to enhance shareholder value and improve stock liquidity.

Dec 13, 2025

SBC Medical Group Holdings: Announcement of Final Results of Tender Offer for Waqoo, Inc. Shares Strategic acquisition strengthens SBC's comprehensive service offerings and R&D capabilities TOKYO, Japan &#x2013

SBC Medical Group Holdings has successfully completed its tender offer for Waqoo, Inc., purchasing 575,052 shares, which will increase its ownership to over 50%. The acquisition, valued at approximately JPY 1,092.5 million, aligns with SBC's strategic efforts to enhance its healthcare technology offerings and expand its market presence in Japan. Settlement for the shares will commence on December 19, 2025, with further shares expected to be acquired from Waqoo's largest shareholder. This strategic move is part of SBC's broader plan to provide comprehensive solutions in the medical sector.

Nov 14, 2025

SBC Medical Group Holdings Announces Third Quarter 2025 Financial Results IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global prov

SBC Medical Group Holdings announced its third-quarter financial results for 2025, reporting a total revenue decrease of 18% year-over-year, amounting to $43 million. Despite the revenue decline, the company experienced a significant increase in net income, up 353% to $13 million. Operating income also improved by 15%, indicating a positive trend in profitability. The company continues to expand its franchise locations and customer base, contributing to a holistic view of business performance amidst ongoing challenges.

Nov 13, 2025

SBC Medical Group Announces Commencement of Tender Offer for Shares of Waqoo, Inc. TOKYO, Japan &#x2013

SBC Medical Group announced a tender offer to acquire shares of Waqoo, Inc., intending to leverage Waqoo's technologies to enhance SBC's clinical offerings. This transaction involves a private share transfer from Waqoo's largest shareholder to SBC's subsidiary and is categorized under related party transactions. The tender offer period is set from November 14 to December 12, 2025, with a pricing strategy favoring SBC. This strategic move aims to accelerate R&D and improve SBC's competitiveness in various medical fields.

Aug 13, 2025

SBC Medical Group Holdings Announces Second Quarter 2025 Financial Results

SBC Medical Group Holdings reported its financial results for the second quarter of fiscal year 2025, detailing significant declines in revenue and profitability. Total revenues decreased by 18% to $43 million, and net income attributable to the company plummeted by 87% compared to the same quarter in the previous year. Despite these declines, the number of franchise locations and customer visits increased, suggesting some aspects of growth amid financial setbacks. The company attributed the revenue drop primarily to strategic shifts, including the discontinuation of its staffing business and a revised fee structure.

Jul 17, 2025

SBC Medical Group Acquires MB Career Lounge "JUN CLINIC" Joins the Group, Strengthening Competitive Position in a Growing Market

SBC Medical Group Holdings has acquired MB Career Lounge, which operates JUN CLINIC, enhancing its aesthetic services portfolio. This acquisition supports SBC Medical's strategy of expanding its network and improving its financial performance. The acquisition is anticipated to diversify the company's service offerings while addressing the increasing demand for personalized aesthetic solutions in Japan's growing market. Yoshiyuki Aikawa, CEO, emphasized the importance of this move in relation to long-term shareholder value and company growth.

Jun 30, 2025

SBC Medical added to membership of Russell 3000 Index IRVINE, Calif. - SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical"), a global franchise and provider of services for aesthetic clinics, has been ad

SBC Medical Group Holdings Incorporated has been added to the Russell 3000 Index, effective June 30. This inclusion provides access to broader markets and increased visibility among institutional investors. The Russell indexes serve as important benchmarks for investment funds, which may enhance SBC Medical's standing in the financial markets. The company, based in Irvine, California, offers a variety of management services to aesthetic clinics, indicating a growing relevance in the aesthetic healthcare sector.

May 15, 2025

SBC Medical Group Holdings Announces First Quarter 2025 Financial Results Irvine, Calif.

SBC Medical Group Holdings has reported its financial results for the first quarter of 2025, highlighting a 14% year-over-year revenue decrease primarily due to discontinuations of certain business segments. However, the company saw a significant improvement in its operating margin, rising from 45% to 51%, and net income increased by 15% compared to the previous year. SBC is positioning itself for strategic expansion while experiencing rising global demand for aesthetic medical services. The company is optimistic about its transition and long-term growth prospects despite facing some operational challenges.

SBC Medical Group Holdings Inc. Announces Fourth Quarter and Full Year 2024 Financial Results Irvine, California, U.S.A.

SBC Medical Group Holdings announced its fourth-quarter and full-year 2024 financial results, highlighting mixed performance metrics. While the company recorded an 18% increase in net income year-over-year, there was a significant 29% decline in total revenues for the fourth quarter. Furthermore, the earnings per share saw a notable drop of 58% compared to the same period last year. Despite these setbacks in the fourth quarter, SBC Medical recorded a year-over-year increase in revenues and gross profit for the entirety of 2024, illustrating an overall growth trajectory in a challenging market environment.

Feb 18, 2025

SBC Medical Group Holdings Announces its Purchase of Bitcoin TOKYO-(BUSINESS WIRE)-SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company") today announced that it has made a decision to pur

SBC Medical Group Holdings Incorporated has announced its decision to purchase Bitcoin, totaling approximately 1 billion yen, as part of its strategic initiatives to enhance financial stability and asset diversification. This move aims to adapt to macroeconomic conditions and is seen as a vital step for sustainable growth. The company plans to execute this purchase through Coinbase and emphasizes adherence to rigorous risk management measures. SBC Medical is committed to maintaining transparency and sharing updates on its initiatives with stakeholders.

Nov 13, 2024

SBC Medical Group Holdings Inc. Reports Third Quarter 2024 Financial Results Irvine, California, U.S.A., Nov, 13, 2024 (Newswire) - SBC Medical Group Holdings Incorporated ("SBC Medical", or the "Company"), a global owne

SBC Medical Group Holdings Inc. announced its financial results for the third quarter of 2024, reporting total revenues of $53 million, a 12% year-over-year increase. Despite a significant overall increase in revenue and net income for the first nine months of the year, the company faced challenges with a 31% decline in income from operations for Q3 due to high stock-based compensation expenses. Total operating expenses also saw a considerable rise. Nevertheless, SBC Medical maintains a strong liquidity position with $137 million in cash.

SBC MEDICAL GROUP HOLDINGS INCORPORATED INDEX TO FINANCIAL STATEMENTS Page Consolidated Balance Sheets as of

SBC Medical Group Holdings Incorporated reported its unaudited financial statements as of June 30, 2024, revealing a strong increase in net income to $18.48 million compared to $10.67 million in the prior year. Total revenues for the first half of the year reached $107.91 million, up from $83.91 million. However, the company faced challenges with an increased accumulated other comprehensive loss and negative foreign currency translation adjustments. Overall, the financials indicate a positive trend in operational performance.

Feb 2, 2023

SBC Medical Group Holdings Incorporated, a medical services healthcare company, announced signing of a definitive agreement to go public via a business combination with Pono Capital Two, Inc., a Nasdaq listed company. Ho

SBC Medical Group Holdings Incorporated has signed a definitive agreement to merge with Pono Capital Two, Inc., a listed SPAC. The merger is expected to enhance SBC's position in the global medical services market. Following the merger, SBC will rebrand and utilize proceeds for expanding operations and developing new product lines. Approval from both companies' stockholders is required for the transaction to proceed, which is anticipated to close in late 2023 or early 2024.

Sep 23, 2022

Pono Capital Two, Inc. Announces the Separate Trading of Its Class A Common Stock and Warrants HONOLULU, HAWAII

Capital Two, Inc. Announces the Separate Trading of Its Class A Common Stock and Warrants HAWAII - September 23, 2022 - Pono Capital Two, Inc. (the "Company") a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock pu

Aug 9, 2022

PONO CAPITAL TWO, INC. INDEX TO FINANCIAL STATEMENT Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of

TO FINANCIAL STATEMENT Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of August 9, 2022 F-3 Notes to Financial Statement F-4 OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM the Stockholders and Board of Directors of on the Financial Statement

Aug 4, 2022